BioRestorative Total Assets from 2010 to 2024

BRTX Stock

USD 1.46 0.01 0.68%

BioRestorative Therapies Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2009-12-31

Previous Quarter

16.1 M

Current Value

14.6 M

Quarterly Volatility

6.3 M

Credit Downgrade

Yuan Drop

Covid

Check BioRestorative Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioRestorative Therapies' main balance sheet or income statement drivers, such as Interest Expense of 12.7 K, Selling General Administrative of 7.4 M or Depreciation And Amortization of 177.8 K, as well as many indicators such as Price To Sales Ratio of 47.82, Dividend Yield of 0.0 or PTB Ratio of 0.77. BioRestorative financial statements analysis is a perfect complement when working with BioRestorative Therapies Valuation or Volatility modules.

Check out the analysis of BioRestorative Therapies Correlation against competitors.

For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.

Latest BioRestorative Therapies' Total Assets Growth Pattern

Below is the plot of the Total Assets of BioRestorative Therapies over the last few years. Total assets refers to the total amount of BioRestorative Therapies assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in BioRestorative Therapies books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. BioRestorative Therapies' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioRestorative Therapies' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 12.61 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

BioRestorative Total Assets Regression Statistics

	Arithmetic Mean	5,963,618
	Geometric Mean	2,986,367
	Coefficient Of Variation	116.38
	Mean Deviation	5,694,809
	Median	1,758,607
	Standard Deviation	6,940,534
	Sample Variance	48.2T
	Range	22.2M
	R-Value	0.64
	Mean Square Error	30.5T
	R-Squared	0.41
	Significance	0.01
	Slope	996,870
	Total Sum of Squares	674.4T

BioRestorative Total Assets History

	2024	13.2 M
	2023	12.6 M
	2022	16.4 M
	2021	22.5 M
	2020	4.3 M
	2019	1.5 M
	2018	1.2 M

Other Fundumenentals of BioRestorative Therapies

Intangibles To Total Assets

BioRestorative Therapies Total Assets component correlations

	Total Assets	Total Stockholder Equity	Accounts Payable	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Net Debt	Retained Earnings	Long Term Debt	Total Current Assets	Treasury Stock	Short Term Debt	Current Deferred Revenue	Net Tangible Assets	Short Long Term Debt	Net Receivables	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Debt Total	Capital Surpluse
Total Assets		0.96	-0.64	-0.73	0.05	-0.29	0.24	-0.84	-0.8	-0.39	0.97	0.38	-0.6	-0.47	0.93	-0.66	-0.53	0.95	0.95	-0.03	-0.39	-0.39
Total Stockholder Equity	0.96		-0.72	-0.88	0.16	-0.13	0.12	-0.82	-0.68	-0.4	0.91	0.38	-0.74	-0.58	0.91	-0.66	-0.4	0.91	0.92	-0.01	-0.38	-0.38
Accounts Payable	-0.64	-0.72		0.73	-0.23	-0.35	0.35	0.44	0.39	-0.1	-0.58	-0.34	0.53	0.6	-0.6	0.26	0.09	-0.61	-0.65	-0.28	0.34	0.34
Total Liab	-0.73	-0.88	0.73		-0.33	-0.17	0.12	0.64	0.36	0.36	-0.64	-0.3	0.85	0.67	-0.71	0.56	0.1	-0.68	-0.72	-0.03	0.3	0.3
Intangible Assets	0.05	0.16	-0.23	-0.33		0.24	-0.24	0.02	0.34	-0.23	-0.2	-0.1	-0.2	-0.21	-0.18	0.27	0.34	-0.18	-0.18	-0.1	0.08	0.08
Common Stock	-0.29	-0.13	-0.35	-0.17	0.24		-0.64	0.18	0.52	0.6	-0.33	-0.22	-0.18	-0.23	-0.32	0.42	0.53	-0.28	-0.27	0.14	0.22	0.22
Property Plant Equipment	0.24	0.12	0.35	0.12	-0.24	-0.64		-0.11	-0.42	-0.32	0.27	0.28	0.11	0.14	0.27	-0.28	-0.33	0.22	0.16	-0.37	-0.16	-0.16
Net Debt	-0.84	-0.82	0.44	0.64	0.02	0.18	-0.11		0.53	0.33	-0.83	-0.11	0.56	0.34	-0.74	0.59	0.43	-0.84	-0.81	0.01	0.1	0.1
Retained Earnings	-0.8	-0.68	0.39	0.36	0.34	0.52	-0.42	0.53		0.2	-0.86	-0.56	0.41	0.07	-0.86	0.76	0.8	-0.82	-0.84	-0.15	0.53	0.53
Long Term Debt	-0.39	-0.4	-0.1	0.36	-0.23	0.6	-0.32	0.33	0.2		-0.32	-0.23	0.21	0.4	-0.39	0.35	0.1	-0.29	-0.3	0.48	0.23	0.23
Total Current Assets	0.97	0.91	-0.58	-0.64	-0.2	-0.33	0.27	-0.83	-0.86	-0.32		0.4	-0.55	-0.42	0.96	-0.71	-0.59	0.98	0.98	-0.01	-0.4	-0.4
Treasury Stock	0.38	0.38	-0.34	-0.3	-0.1	-0.22	0.28	-0.11	-0.56	-0.23	0.4		-0.35	-0.31	0.6	-0.43	-0.3	0.33	0.4	-0.07	-0.8	-0.8
Short Term Debt	-0.6	-0.74	0.53	0.85	-0.2	-0.18	0.11	0.56	0.41	0.21	-0.55	-0.35		0.32	-0.66	0.74	0.28	-0.59	-0.65	-0.26	0.34	0.34
Current Deferred Revenue	-0.47	-0.58	0.6	0.67	-0.21	-0.23	0.14	0.34	0.07	0.4	-0.42	-0.31	0.32		-0.48	0.01	-0.31	-0.41	-0.42	0.46	0.31	0.31
Net Tangible Assets	0.93	0.91	-0.6	-0.71	-0.18	-0.32	0.27	-0.74	-0.86	-0.39	0.96	0.6	-0.66	-0.48		-0.79	-0.56	0.93	0.96	0.01	-0.6	-0.6
Short Long Term Debt	-0.66	-0.66	0.26	0.56	0.27	0.42	-0.28	0.59	0.76	0.35	-0.71	-0.43	0.74	0.01	-0.79		0.66	-0.72	-0.78	-0.34	0.42	0.42
Net Receivables	-0.53	-0.4	0.09	0.1	0.34	0.53	-0.33	0.43	0.8	0.1	-0.59	-0.3	0.28	-0.31	-0.56	0.66		-0.57	-0.58	-0.25	0.28	0.28
Net Invested Capital	0.95	0.91	-0.61	-0.68	-0.18	-0.28	0.22	-0.84	-0.82	-0.29	0.98	0.33	-0.59	-0.41	0.93	-0.72	-0.57		0.98	0.08	-0.27	-0.27
Net Working Capital	0.95	0.92	-0.65	-0.72	-0.18	-0.27	0.16	-0.81	-0.84	-0.3	0.98	0.4	-0.65	-0.42	0.96	-0.78	-0.58	0.98		0.14	-0.4	-0.4
Capital Stock	-0.03	-0.01	-0.28	-0.03	-0.1	0.14	-0.37	0.01	-0.15	0.48	-0.01	-0.07	-0.26	0.46	0.01	-0.34	-0.25	0.08	0.14		0.07	0.07
Long Term Debt Total	-0.39	-0.38	0.34	0.3	0.08	0.22	-0.16	0.1	0.53	0.23	-0.4	-0.8	0.34	0.31	-0.6	0.42	0.28	-0.27	-0.4	0.07		1.0
Capital Surpluse	-0.39	-0.38	0.34	0.3	0.08	0.22	-0.16	0.1	0.53	0.23	-0.4	-0.8	0.34	0.31	-0.6	0.42	0.28	-0.27	-0.4	0.07	1.0

Click cells to compare fundamentals

About BioRestorative Therapies Financial Statements

BioRestorative Therapies investors use historical fundamental indicators, such as BioRestorative Therapies' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioRestorative Therapies. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	12.6 M	13.2 M
Intangibles To Total Assets	0.06	0.05

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for BioRestorative Stock Analysis

When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC